|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61K 31/70 | |||
| C07H 21/00 | |||
| A61K 31/7088 |
| (11) | Number of the document | 2134364 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08726518.7 |
| Date of filing the European patent application | 2008-03-06 | |
| (97) | Date of publication of the European application | 2009-12-23 |
| (45) | Date of publication and mention of the grant of the patent | 2013-02-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/003001 |
| Date | 2008-03-06 |
| (87) | Number | WO 2008/112129 |
| Date | 2008-09-18 |
| (30) | Number | Date | Country code |
| 905944 P | 2007-03-09 | US |
| (72) |
TRESSLER, Robert, J., US
GO, Ning, US
|
| (73) |
Geron Corporation,
149 Commonwealth Drive, Menlo Park, CA 94025,
US
|
| (54) | TREATMENT OF CARCINOMAS WITH A COMBINATION OF EGF-PATHWAY AND TELOMERASE INHIBITORS |
| TREATMENT OF CARCINOMAS WITH A COMBINATION OF EGF-PATHWAY AND TELOMERASE INHIBITORS |